Scarica l'app Stockscreener
1.02
5.56%
-0.06
Pre-mercato:
1.10
0.08
+7.84%
Precedente Chiudi:
$1.08
Aprire:
$1.05
Volume 24 ore:
37,259
Relative Volume:
1.34
Capitalizzazione di mercato:
$41.91M
Reddito:
-
Utile/perdita netta:
$-7.92M
Rapporto P/E:
-3.40
EPS:
-0.3
Flusso di cassa netto:
$-7.05M
1 W Prestazione:
-25.00%
1M Prestazione:
-2.86%
6M Prestazione:
-47.69%
1 anno Prestazione:
-64.95%
Intervallo 1D:
$1.00
$1.07
Intervallo di 1 settimana:
$1.00
$1.40
Portata 52W:
$0.8001
$3.30
Anebulo Pharmaceuticals Inc Stock (ANEB) Company Profile
Nome
Anebulo Pharmaceuticals Inc
Settore
Industria
Telefono
737 203 5270
Indirizzo
JFL CAPITAL MANAGEMENT, LAKEWAY
Confronta ANEB con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ANEB
Anebulo Pharmaceuticals Inc
|
1.02 | 41.91M | 0 | -7.92M | -7.05M | -0.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.62 | 121.88B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.45 | 62.69B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
555.11 | 33.86B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
235.74 | 30.51B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
238.51 | 25.69B | 3.81B | -644.79M | -669.77M | -6.24 |
Anebulo Pharmaceuticals Inc Borsa (ANEB) Ultime notizie
Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) Short Interest Down 12.3% in March - Defense World
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Mangrove Partners IM, LLC Acquires Significant Stake in Anebulo Pharmaceuticals Inc - GuruFocus
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Anebulo Pharmaceuticals Inc Files For Resale Of Up To 15.15 Million Shares By The Selling Stockholders - Marketscreener.com
Benchmark maintains Speculative Buy on Anebulo stock, target at $8 By Investing.com - Investing.com Canada
Anebulo Pharmaceuticals enters lock-up agreement, faces Nasdaq compliance issue By Investing.com - Investing.com South Africa
Anebulo Pharmaceuticals enters lock-up agreement, faces Nasdaq compliance issue - Investing.com
Anebulo Pharmaceuticals files to sell 15.15M shares of common stock for holders - MSN
Anebulo Pharmaceuticals Reports Fiscal Q2 2025 Results - TipRanks
Anebulo Pharmaceuticals Inc Files Prospectus Related To Resale Of 15.2 Million Shares Of Common Stock By Selling Stockholders- SEC Filing - Marketscreener.com
Anebulo Pharmaceuticals Inc. (ANEB) reports earnings - Quartz
Anebulo Pharmaceuticals Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Anebulo Pharmaceuticals, Inc. SEC 10-Q Report - TradingView
Anebulo's Cannabis Overdose Treatment Gets FDA Priority Signal as Company Raises $15M - StockTitan
Head to Head Contrast: ProQR Therapeutics (NASDAQ:PRQR) versus Anebulo Pharmaceuticals (NASDAQ:ANEB) - Defense World
Anebulo Pharmaceuticals sets annual meeting for April 4, 2025 By Investing.com - Investing.com Nigeria
Anebulo Pharmaceuticals sets annual meeting for April 4, 2025 - MSN
Anebulo Pharmaceuticals Leads This Trio Of US Penny Stocks - Yahoo Finance
Short Interest in Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) Increases By 2,174.1% - Defense World
Short Interest in Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) Expands By 2,174.1% - Defense World
3 US Penny Stocks With Market Caps Under $800M - Yahoo Finance
Anebulo Pharmaceuticals sees $9.99m stock acquisition by 22NW fund - Investing.com Australia
Anebulo Pharmaceuticals collaborates with FDA to advance selonabant - Yahoo Finance
Anebulo Pharmaceuticals Announces Positive Regulatory Update for Selonabant in Acute Cannabis-Induced Toxicity in Children and Capital Raise - BioSpace
Anebulo Pharmaceuticals secures $15 million capital raise - Investing.com
Anebulo Reports Breakthrough Clinical Data for Cannabis Toxicity Treatment, Secures $15M Funding - StockTitan
Anebulo Pharmaceuticals (NASDAQ:ANEB) Stock Price Down 9.8% – Should You Sell? - Defense World
Anebulo Pharmaceuticals stock hits 52-week low at $1.23 - Investing.com India
Anebulo Pharmaceuticals stock hits 52-week low at $1.23 By Investing.com - Investing.com South Africa
Anebulo Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2024 - Marketscreener.com
Anebulo Pharmaceuticals stock hits 52-week low at $1.25 By Investing.com - Investing.com Australia
Anebulo Pharmaceuticals stock hits 52-week low at $1.25 - Investing.com India
Anebulo Pharmaceuticals Advances Cannabis Toxicity Solutions - MSN
Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2025 Financial Results and Recent Updates - Defense World
Anebulo Pharma Secures $1.9M NIDA Grant for Cannabis Toxicity Treatment Development | ANEB Stock News - StockTitan
Anebulo Pharmaceuticals stock hits 52-week low at $1.72 - Investing.com
Anebulo Pharmaceuticals stock hits 52-week low at $1.72 By Investing.com - Investing.com UK
Exxaro Resources (OTCMKTS:EXXAY) Share Price Crosses Above 200 Day Moving Average – What’s Next? - Defense World
Lexeo Therapeutics’ (LXEO) “Buy” Rating Reiterated at Chardan Capital - Defense World
Anebulo Pharmaceuticals Inc Azioni (ANEB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.01%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):